Inspire Medical Systems, Inc. Payments to Acquire Debt Securities, Available-for-sale
Inspire Medical Systems, Inc. (INSP) reported Payments to Acquire Debt Securities, Available-for-sale of $82.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-03
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $24.93M, a 73.45% decline year-over-year.
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $57.31M, a 230.92% increase year-over-year.
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $62.94M, a 22.11% decline year-over-year.
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $66.14M, a 70.67% decline year-over-year.
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for fiscal 2025 was $240.32M, a 42.56% decline from fiscal 2024.
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for fiscal 2024 was $418.35M, a 48.78% increase from fiscal 2023.
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $281.19M.
- Inspire Medical Systems, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 3 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 6 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $82.25M 10-Q · filed 2026-08-03 | $145.19M derived: sum of 3 quarters · filed 2026-08-03 | $211.33M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $57.31M 10-Q · filed 2026-05-04 | $120.25M derived: sum of 2 quarters · filed 2026-05-04 | $186.39M derived: sum of 3 quarters · filed 2026-05-04 | $280.31M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $62.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $129.08M derived: sum of 2 quarters · filed 2026-02-13 | $223.00M derived: sum of 3 quarters · filed 2026-08-03 | $240.32M 10-K · filed 2026-02-13 | ||
| 2025-09-30 | $66.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $160.06M derived: sum of 2 quarters · filed 2026-08-03 | $177.38M 10-Q · filed 2025-11-03 | $258.19M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $93.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $111.24M 10-Q · filed 2026-08-03 | $108.72M 10-Q · filed 2025-08-04 | $192.05M derived: sum of 3 quarters · filed 2026-08-03 | $417.56M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $17.32M 10-Q · filed 2026-05-04 | $16.72M 10-Q · filed 2025-05-05 | $98.13M derived: sum of 2 quarters · filed 2026-05-04 | $323.64M derived: sum of 3 quarters · filed 2026-05-04 | $379.93M derived: sum of 4 quarters · filed 2026-05-04 | |
| 2024-12-31 | $80.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $306.32M derived: sum of 2 quarters · filed 2026-02-13 | $362.62M derived: sum of 3 quarters · filed 2026-02-13 | $418.35M 10-K · filed 2026-02-13 | ||
| 2024-09-30 | $225.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $281.80M derived: sum of 2 quarters · filed 2025-11-03 | $337.54M 10-Q · filed 2025-11-03 | $481.48M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-06-30 | $56.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $112.03M 10-Q · filed 2025-08-04 | $255.97M derived: sum of 3 quarters · filed 2026-02-13 | $393.22M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-03-31 | $55.74M 10-Q · filed 2025-05-05 | $199.68M derived: sum of 2 quarters · filed 2026-02-13 | $336.93M derived: sum of 3 quarters · filed 2026-02-13 | $336.93M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2023-12-31 | $143.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $281.19M derived: sum of 2 quarters · filed 2026-02-13 | $281.19M derived: sum of 3 quarters · filed 2026-02-13 | $281.19M 10-K · filed 2026-02-13 | ||
| 2023-09-30 | $137.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $137.25M derived: sum of 2 quarters · filed 2024-11-04 | $137.25M 10-Q · filed 2024-11-04 | $137.25M derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-02-10 | $0.00 derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-10 | $0.00 derived: sum of 3 quarters · filed 2025-02-10 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $0.00 derived: sum of 2 quarters · filed 2025-02-10 | $0.00 10-K · filed 2025-02-10 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-02 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-09 | $9.99M 10-K · filed 2024-02-09 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $9.99M 10-Q · filed 2022-11-01 | ||||
| 2021-06-30 | $9.99M 10-Q · filed 2022-08-02 | |||||
| 2020-12-31 | $52.72M 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |